Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 8, 2023
- Accepted May 16, 2023
- Published online June 1, 2023.
Article Versions
- You are currently viewing a previous version of this article (June 1, 2023 - 06:35).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2023. For reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Yet H. Khor1,2,3,4⇑,
- Vincent Cottin5,6,
- Anne E. Holland1,3,7,8,
- Yoshikazu Inoue9,
- Vanessa M. McDonald10,11,12,
- Justin Oldham13,14,
- Elisabetta A. Renzoni15,16,
- Anne Marie Russell17,18,19,
- Mary E. Strek20 and
- Christopher J. Ryerson21,22
- 1Respiratory Research@Alfred, Central Clinical School, Monash University, Melbourne, Victoria, Australia
- 2Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia
- 3Institute for Breathing and Sleep, Heidelberg, Victoria, Australia
- 4Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia
- 5National Coordinating Reference Centre for Rare Pulmonary Diseases, OrphaLung, Louis Pradel Hospital, Hospices Civils de Lyon, ERN-LUNG, Lyon, France
- 6UMR 754, Claude Bernard University Lyon 1, INRAE, Lyon, France
- 7Department of Respiratory and Sleep Medicine, Alfred Health, Melbourne, Victoria, Australia
- 8Department of Physiotherapy, Alfred Health, Melbourne, Victoria, Australia
- 9Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Osaka, Japan
- 10National Health and Medical Research Council Centre for Research Excellence in Treatable Traits, New Lambton Heights, NSW, Australia
- 11Asthma and Breathing Research Centre, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia
- 12School of Nursing and Midwifery, College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW, Australia
- 13Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
- 14Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA
- 15Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas’ NHS Foundation Trust, London, UK
- 16Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK
- 17Exeter Respiratory Innovation Centre, University of Exeter, Exeter, UK
- 18Royal Devon University Hospitals, NHS Foundation Trust, Devon, UK
- 19Faculty of Medicine, Imperial College Healthcare NHS Trust, London, UK
- 20Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois, USA
- 21Department of Medicine, University of British Columbia, Vancouver, BC, Canada
- 22Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada
- Corresponding author: Yet Khor (yet.khor{at}monash.edu)
Funding
National Health and Medical Research Council
2008255
Article usage
Altmetrics
Vol 62 Issue 5
Table of Contents
Treatable traits: a comprehensive precision medicine in interstitial lung disease
